Wednesday, December 3, 2014

Imprimis Pharmaceuticals Expands Proprietary Ophthalmic Formulations to Four Key West States


Imprimis Pharmaceuticals Expands Proprietary Ophthalmic Formulations to Four Key West...
Imprimis is pioneering a new commercial pathway using compounding pharmacies for the formulation and distribution of its proprietary drug therapies, ...

No comments: